China: Plant Engineering Jiatong Energy Signs PTA Technology Contract with IPT
Jiangsu Jiatong Energy has entered into an agreement with Invista Performance Technologies (IPT) to license Invista’s latest P8 PTA technology for its dual PTA lines in China. The expected start-up date for the first line of the Jiatong project is Q4 2022. Vortext
Shanghai/China – Invista Textiles’ (U.K.) technology and licensing business, Invista Performance Technologies (IPT), and Jiangsu Jiatong Energy Co., a subsidiary of Tongkun Group (Tongkun), have reached an agreement to license Invista’s latest P8 PTA technology for two PTA lines.
These two lines will be installed in Rudong, Nantong City, Jiangsu province, China. Both lines deploy Invista’s largest twin stream design respectively, utilising Invista’s latest P8++ PTA technology. Building on the demonstrated performance of the P8 technology platform, the variable cost, capital productivity and environmental performance is expected to set new benchmarks within the industry.
Tongkun and Invista have been working together for 10 years in PTA. Invista’s first P7 and first P8 technology platforms were successfully installed, commissioned, and operated at another subsidiary (Jiaxing Petrochemical) of Tongkun Group. Based on the successful co-operation on these projects, Tongkun has again selected Invista’s latest P8++ PTA technology for the Jiatong project.
Adam Sackett, IPT vice president PTA, commented, “We are honoured that our industry-leading P8++ PTA technology has been selected again by Tongkun Group. Our companies have a long history of PTA innovation, and we look forward to working together on this new chapter of technology and cooperation between the two parties.”
A kick-off meeting was successfully concluded on August 15, 2020, by Jiatong, Invista and CTCI (the engineering contractor). A project start-up date of Q4 2022 is targeted for the first line.
Invista’s industry-leading PTA technology, including its latest version of P8 technology, is available as a license package from IPT.